Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors (AflacST1901)

NCT04334863 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04334863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors (AflacST1901)
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
May 4, 2020
Completion date
February 3, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, brain tumor, medulloblastoma